EP2012756A4 - Zusammensetzungen mit mehreren einheiten - Google Patents

Zusammensetzungen mit mehreren einheiten

Info

Publication number
EP2012756A4
EP2012756A4 EP07734348A EP07734348A EP2012756A4 EP 2012756 A4 EP2012756 A4 EP 2012756A4 EP 07734348 A EP07734348 A EP 07734348A EP 07734348 A EP07734348 A EP 07734348A EP 2012756 A4 EP2012756 A4 EP 2012756A4
Authority
EP
European Patent Office
Prior art keywords
multiple unit
unit compositions
compositions
unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07734348A
Other languages
English (en)
French (fr)
Other versions
EP2012756A2 (de
Inventor
Amit Krishna Antarkar
Sunil Beharilal Jaiswal
Maya Janak Shah
Abdul Shajahan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inventia Healthcare Pvt Ltd
Original Assignee
Inventia Healthcare Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventia Healthcare Pvt Ltd filed Critical Inventia Healthcare Pvt Ltd
Publication of EP2012756A2 publication Critical patent/EP2012756A2/de
Publication of EP2012756A4 publication Critical patent/EP2012756A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07734348A 2006-04-20 2007-04-16 Zusammensetzungen mit mehreren einheiten Withdrawn EP2012756A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN627MU2006 2006-04-20
PCT/IB2007/001029 WO2007122478A2 (en) 2006-04-20 2007-04-16 Multiple unit compositions

Publications (2)

Publication Number Publication Date
EP2012756A2 EP2012756A2 (de) 2009-01-14
EP2012756A4 true EP2012756A4 (de) 2013-01-23

Family

ID=38625366

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07734348A Withdrawn EP2012756A4 (de) 2006-04-20 2007-04-16 Zusammensetzungen mit mehreren einheiten

Country Status (3)

Country Link
US (1) US20090068263A1 (de)
EP (1) EP2012756A4 (de)
WO (1) WO2007122478A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2254556A2 (de) 2008-03-11 2010-12-01 Takeda Pharmaceutical Company Limited Im mund zerfallendes feststoffpräparat
TWI519322B (zh) 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
EP2133072A1 (de) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Magenresistente orale pharmazeutische Zusammensetzungen mit Duloxetin oder pharmazeutisch zulässigen Derivaten
CN101366703B (zh) * 2008-10-10 2012-02-01 寿光富康制药有限公司 奥美拉唑肠溶微丸制剂及制备方法
DE102009033621A1 (de) * 2009-07-17 2011-01-20 Add Technologies Ltd. Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
US20130216617A1 (en) * 2010-06-29 2013-08-22 Cadila Healthcare Limited Pharmaceutical compositions of (r)-lansoprazole
AU2011281290A1 (en) * 2010-07-22 2013-02-14 Lupin Limited Multiple unit tablet composition
EP2604256B1 (de) * 2011-12-14 2016-04-13 Hexal AG Mehrschichtige Beschichtungen
CN103565770A (zh) * 2012-07-31 2014-02-12 北京阜康仁生物制药科技有限公司 一种右兰索拉唑肠溶缓控释微丸片
EP2882425B1 (de) * 2012-08-10 2019-07-10 Indoco Remedies Limited Neuartige pharmazeutische zusammensetzung aus linezolid
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2015038854A1 (en) * 2013-09-13 2015-03-19 R.P. Scherer Technologies, Llc Encased-pellet tablets
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018175648A1 (en) * 2017-03-21 2018-09-27 Bioduro, Llc Gastrointestinal-protective formulations for oral delivery of proteins and peptides
WO2022118107A1 (en) * 2020-12-03 2022-06-09 Johnson & Johnson Consumer Inc. Multi-layered particle comprising simethicone
CN114099462B (zh) * 2021-12-03 2023-11-17 宁波高新区美诺华医药创新研究院有限公司 度洛西汀延迟释放药物组合物及制备方法

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
WO1999027917A1 (de) * 1997-11-28 1999-06-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Arzneimittelzubereitung in tabletten- oder pelletform für säurelabile wirkstoffe
DE19801811A1 (de) * 1998-01-19 1999-07-22 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
JP2000212085A (ja) * 1999-01-27 2000-08-02 Nanko Kagaku Seiyaku Kofun Yugenkoshi オメプラゾ―ル又はその他類似物を含有する高安定性経口医薬製剤及びその製法
US6328994B1 (en) * 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
WO2002072070A1 (en) * 2001-03-09 2002-09-19 Astrazeneca Ab Method to obtain microparticles containing a h+, k+-atp-ase inhibitor
WO2004035020A2 (en) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited Controlled release preparation
US20050191353A1 (en) * 2002-08-16 2005-09-01 Amit Krishna Antarkar Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
US20050244497A1 (en) * 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
WO2005105054A1 (en) * 2004-04-15 2005-11-10 Dr. Reddy's Laboratories Ltd. Dosage form having polymorphic stability
WO2006066932A1 (en) * 2004-12-24 2006-06-29 Lek Pharmaceuticals D.D. Stable pharmaceutical composition comprising an active substance in the form of solid solution
EP1967211A1 (de) * 2005-12-28 2008-09-10 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
CA2328154A1 (en) * 1998-04-17 1999-10-28 Taisho Pharmaceutical Co., Ltd. Multiple-unit sustained release tablets
GB9921933D0 (en) * 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
ATE454906T1 (de) * 2003-07-11 2010-01-15 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
US20080146615A1 (en) * 2004-12-20 2008-06-19 Dr. Reddy's Laboratories Limited Pharmaceutical Compositions Comprising Amorphous Benzimidazole Compounds
US20070141151A1 (en) * 2005-12-20 2007-06-21 Silver David I Lansoprazole orally disintegrating tablets

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US20050244497A1 (en) * 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
WO1999027917A1 (de) * 1997-11-28 1999-06-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Arzneimittelzubereitung in tabletten- oder pelletform für säurelabile wirkstoffe
DE19801811A1 (de) * 1998-01-19 1999-07-22 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
US6328994B1 (en) * 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
JP2000212085A (ja) * 1999-01-27 2000-08-02 Nanko Kagaku Seiyaku Kofun Yugenkoshi オメプラゾ―ル又はその他類似物を含有する高安定性経口医薬製剤及びその製法
WO2002072070A1 (en) * 2001-03-09 2002-09-19 Astrazeneca Ab Method to obtain microparticles containing a h+, k+-atp-ase inhibitor
US20050191353A1 (en) * 2002-08-16 2005-09-01 Amit Krishna Antarkar Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
WO2004035020A2 (en) * 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited Controlled release preparation
WO2005105054A1 (en) * 2004-04-15 2005-11-10 Dr. Reddy's Laboratories Ltd. Dosage form having polymorphic stability
WO2006066932A1 (en) * 2004-12-24 2006-06-29 Lek Pharmaceuticals D.D. Stable pharmaceutical composition comprising an active substance in the form of solid solution
EP1967211A1 (de) * 2005-12-28 2008-09-10 Takeda Pharmaceutical Company Limited Verfahren zur herstellung eines sich in der mundhöhle zersetzenden feststoffpräparats

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BALDI FABIO; MALFERTHEINER PETER: "Lansoprazole fast disintegrating tablet: A new formulation for an established proton pump inhibitor", DIGESTION, vol. 67, no. 1-2, 2003, pages 1 - 5, XP002689117 *
DATABASE WPI Section Ch Week 200058, Derwent World Patents Index; Class A96, AN 2000-604769, XP002689118, HSIEH P; HSU T; KYO S; O G; SHA H; SHIE P; SHIU T; WANG Y: "Oral pharmaceutical formulation containing omeprazole has coating of omeprazole and specified amount of globular form fine granule like nucleus parts with polyvinyl alcohol, intermediate and enteric coating layer" *
SHIMIZU T ET AL: "FORMULATION STUDY FOR LANSOPRAZOLE FAST-DISINTEGRATING TABLET. II. EFFECT OF TRIETHYL CITRATE ON THE QUALITY OF THE PRODUCTS", CHEMICAL & PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, JP, vol. 51, no. 9, 1 October 2003 (2003-10-01), pages 1029 - 1035, XP001174705, ISSN: 0009-2363, DOI: 10.1248/CPB.51.1029 *

Also Published As

Publication number Publication date
WO2007122478A3 (en) 2008-01-10
WO2007122478A2 (en) 2007-11-01
EP2012756A2 (de) 2009-01-14
US20090068263A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
EP2040708A4 (de) Quercetinhaltige zusammensetzungen
EP2012756A4 (de) Zusammensetzungen mit mehreren einheiten
GB0625069D0 (en) Compositions
GB0620279D0 (en) Compositions
GB0618657D0 (en) Compositions
GB0625586D0 (en) Composition
GB0607605D0 (en) Composition
EP1986849A4 (de) Waschechte schwelen unterdrückende zusammensetzungen
GB0620918D0 (en) Compositions
GB0601899D0 (en) Compositions
GB0611033D0 (en) Compositions
GB0625429D0 (en) Composition
GB0625430D0 (en) Composition
GB0625841D0 (en) Composition
GB0623618D0 (en) Composition
GB0610477D0 (en) Compositions
GB0624424D0 (en) Compositions
GB0622456D0 (en) Compositions
GB0622092D0 (en) Compositions
GB0621950D0 (en) Compositions
GB0621751D0 (en) Compositions
GB0600411D0 (en) Compositions
GB0620204D0 (en) Compositions
GB0615147D0 (en) Composition
GB0605522D0 (en) Composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081117

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE PRIVATE LIMITED

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121221

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4184 20060101ALI20121214BHEP

Ipc: A61K 9/50 20060101ALI20121214BHEP

Ipc: A61K 31/4439 20060101ALI20121214BHEP

Ipc: A61K 31/381 20060101ALI20121214BHEP

Ipc: A61K 9/20 20060101AFI20121214BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE PRIVATE LIMITED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130719